Papers - YOKOYAMA Yoshihito
-
Peroxisome proliferator-activated receptor alpha and gamma inhibit growth of human ovarian cancer. （共著）
Shigeto T, Yokoyama Y, Xin B, Mizunuma H.
Oncology Reports 18 833 - 840 2007.11
-
Para-aortic lymphadenectomy may improve disease-related survival in patients with multipositive pelvic lymph node stage IIIc endometrial cancer.
Toshio Fujimoto, Hiroshi Nanjyo, Akira Nakamura, Yoshihito Yokoyama, Tadao Takano, Tadahiro Shoji, Kenji Nakahara, Hidekazu Yamada, Hideki Mizunuma, Nobuo Yaegashi, Toru Sugiyama, Hirohisa Kurachi, Akira Sato, Toshinobu Tanaka
Gynecologic oncology 107 ( 2 ) 253 - 259 2007.11
-
30歳未満の子宮がん検診（共著）
二神真行、横山良仁、樋口 毅、水沼英樹
産婦人科治療 95 ( 3 ) 254 - 259 2007.9
-
Inhibitory effect of meloxicam, a selective cyclooxygenase-2 inhibitor, and ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, on the growth of human ovarian cancer.（共著）
Xin B, Yokoyama Y, Shigeto T, Futagami M, Mizunuma H.
Cancer 110 791 - 800 2007.6
-
がんの疫学（８）卵巣がん（共著）
中路重之、鎌田梨沙、横山良仁
臨床腫瘍プラクティス 3 ( 2 ) 108 - 117 2007.5
-
Clofibric acid, a peroxisome proliferator–activated receptor α ligand, inhibits growth of human ovarian cancer. （共著）
Yokoyama Y, Xin B, Shigeto T, Umemoto M, Kasai-Sakamoto A, Futagami M, Tsuchida S, Al-Mulla F, Mizunuma H.
Molecular Cancer Therapeutics 6 ( 4 ) 1379 - 1386 2007.4
-
Clofibric acid, a peroxisome proliferator–activated receptor alpha ligand, enhances a suppressive effect of cis-diaminedichloroplatinum on proliferation of ovarian carcinoma cells.（共著）
Yokoyama Y, Xin B, Shigeto T, Futagami M, Mizunuma H.
Clinical Medicine: Oncology 1 ( 1 ) 1 - 6 2007.1
-
若年者と子宮がん検診（共著）
二神真行、横山良仁、樋口 毅、水沼英樹
産婦人科治療 93 ( 6 ) 642 - 648 2006.12
-
肉腫様成分を認めた子宮頸部腺扁平上皮癌の1例（共著）
一戸志津子、宇野恵子、宮古まろみ、桜庭 厚、須藤俊之、坂本知巳、横山良仁、二神真行、佐藤重美
日本臨床細胞学会青森県支部会報 23 41 - 46 2006.11
-
Different susceptibility to peroxisome proliferator-induced hepatocarcinogenesis in rats with polymorphic glutathione transferase genes.（共著）
Kudo T, Asano J, Shimizu T, Nagashima N, Fan Y, Akita M, Ookawa K, Hayakari M, Yokoyama Y, Suto K, Tsuchida S.
Cancer Sciennce 97 ( 8 ) 703 - 709 2006.8
-
Clinical outcome and risk factors for recurrence in borderline ovarian tumours. （共著）
Yokoyama Y, Moriya T, Takano T, Shoji T, Takahashi O, Nakahara K, Yamada H, Yaegashi N, Okamura K, Izutsu T, Sugiyama T, Tanaka T, Kurachi H, Sato A, Tase T, Mizunuma H.
British Journal of Cancer 94 1586 - 1591 2006.5
-
A Case of cellulitis that complicated lymphedema of the lower limb and produced systemic inflammatory response syndrome (SIRS).（共著）
Kasai-Sakamoto A, Yokoyama Y, Mizunuma H.
European Journal Gynaecological Oncology 27 419 - 421 2006.4
-
Pharmacokinetic analysis of paclitaxel and carboplatin in a patient with advanced ovarian cancer during hemodialysis.（共著）
Yokoyama Y, Futagami M, Higuchi T, Mizunuma H.
European Journal Gynaecological Oncology 27 437 - 439 2006.4
-
産婦人科医不足の現状と研修医・医学部学生の産婦人科に対する意識調査（共著）
横山良仁、水沼英樹
セミナー医療と社会 29 3 - 11 2006.1
-
Vascular endothelial growth factor expression in the retinal pigment epithelium is essential for choriocapillaris development and visual function. （共著）
Marneros AG, Fan J, Yokoyama Y, Gerber HP, Ferrara N, Crouch RK, Olsen BR.
American Journal of Pathology 167 1451 - 1459 2005.7
-
Syndrome of inappropriate secretion of anti-diuretic hormone following carboplatin-paclitaxel administration in a patient with recurrent ovarian cancer.（共著）
Yokoyama Y, Shigeto T, Futagami M, Mizunuma H.
European Journal Gynaecological Oncology 26 531 - 532 2005.5
-
The potential and problems of screening for ovarian cancer. （共著）
Yokoyama Y, Higuchi T, Mizunuma H.
European Journal Gynaecological Oncology 26 241 - 243 2005.2
-
Asymptomatic intracardiac metastasis from a low-grade endometrial stromal sarcoma with successful surgical resection.（共著）
Yokoyama Y, Ono Y, Sakamoto T, Fukuda I, Mizunuma H.
Gynecologic Oncology 92 999 - 1001 2004.6
-
Clinical implication of expression of cyclooxygenase-2 and peroxisome proliferator activated-receptor γ in epithelial ovarian tumours. （共著）
Sakamoto A, Yokoyama Y, Umemoto M, Futagami M, Sakamoto T, Bing X, Mizunuma H.
British Journal of Cancer 91 633 - 638 2004.3
-
Expression of vascular endothelial growth factor (VEGF)-D and its receptor, VEGFR-3 as a prognostic factor in endometrial carcinoma. （共著）
Yokoyama Y, Charnock-Jones DS, Licence D, Yanaihara A, Hastings JM, Holland CM, Emoto M, Sakamoto A, Sakamoto T, Maruyama H, Sato S, Mizunuma H, Smith SK.
Clinical Cancer Research 92 1361 - 1369 2003.7